Your browser doesn't support javascript.
loading
ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis.
Pu, Jian; Zhang, Ya; Wang, Anmin; Qin, Zebang; Zhuo, Chenyi; Li, Wenchuan; Xu, Zuoming; Tang, Qianli; Wang, Jianchu; Wei, Huamei.
Affiliation
  • Pu J; Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Zhang Y; Graduate College of Youjiang Medical University for Nationalities, Baise, China.
  • Wang A; Graduate College of Youjiang Medical University for Nationalities, Baise, China.
  • Qin Z; Graduate College of Youjiang Medical University for Nationalities, Baise, China.
  • Zhuo C; Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Li W; Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Xu Z; Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Tang Q; Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Wang J; Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Wei H; Department of Pathology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Front Oncol ; 11: 754835, 2021.
Article in En | MEDLINE | ID: mdl-34733789

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: